Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations

Public reimbursement systems face the challenge of balancing provision of needed treatments and the reality of limited resources. Canada has a complex system for drug approval and public reimbursement, with jurisdiction divided between the federal government and the provinces/territories. A pivotal...

Descripción completa

Detalles Bibliográficos
Autores principales: Binder, Louise, Ghadban, Majd, Sit, Christina, Barnard, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947453/
https://www.ncbi.nlm.nih.gov/pubmed/35323327
http://dx.doi.org/10.3390/curroncol29030127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947453/
https://www.ncbi.nlm.nih.gov/pubmed/35323327
http://dx.doi.org/10.3390/curroncol29030127

Ejemplares similares